Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,059.42
+34.881.72%
Number of Gainers:6
Number of Losers:4
Number of Flat:1
PE:- -
High:2,064.98
Open:2,024.75
Low:2,024.75
Close:2,024.54
Volume:18.19M
Turnover:1.08B
Market Cap:227.94B
Float Cap:227.24B

Loading ...

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
10 hours ago

Quest Diagnostics Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
10 hours ago

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
11 hours ago

Quanterix Names Yuri Fesko as Chief Medical Officer

Reuters
·
Yesterday

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Quest Diagnostics Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

GeoVax Labs Announces Special Shareholder Meeting

Reuters
·
Sep 11

GeoVax Appeals NASDAQ Delisting Notice Tied to Minimum Bid Price Rule

Reuters
·
Sep 11

Apple Health app users can order labs from Quest Diagnostics

TIPRANKS
·
Sep 10

Quest Diagnostics Lab Testing to be Available for Purchase in Apple Health App Later This Year

Reuters
·
Sep 10

Viatris Price Target Announced at $20.00/Share by Leerink Partners

Dow Jones
·
Sep 09

U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software

Reuters
·
Sep 09

Leerink Starts Viatris at 'outperform' on Improving Growth

Reuters
·
Sep 09

Emergent Biosolutions Price Target Maintained with a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 09

Viatris Inc. : Leerink Partners Initiates Coverage with Outperform Rating; Price Target $20

THOMSON REUTERS
·
Sep 09

Viatris initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Dow Jones
·
Sep 09

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update

Reuters
·
Sep 09

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS
·
Sep 09